News - BIOQuébec

5 February 2026
Funding for your RNA therapy innovations!
CQDM, with the support of MEIE under the AReNA program, is funding Quebec-based companies to…
Read more
5 February 2026
Funding Available for Your Biopharmaceutical Projects!
Quantum Leap supports SMEs and universities in carrying out translational biopharmaceutical research…
Read more
5 February 2026
Funding Opportunity to Support Innovation in Quebec’s Biopharma Sector!
SynergiQc, our biopharmaceutical R&D funding program, is designed to support innovation in …
Read more
5 February 2026
EncephalX announces the closing of a $2.25M Pre-Seed Round
EncephalX, a Canadian medtech company, has closed a CAD $2.25M oversubscribed pre-seed round to…
Read more
22 January 2026
adMare BioInnovations Launches Ocythera: A New Canadian Life Sciences Company Advancing Therapies for Rare Bone Diseases
adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to…
Read more
14 January 2026
2026-2027 Budget: For a competitive and innovative Quebec in life sciences and health technologies
BIOQuébec submitted its pre-budget briefing paper, “For a competitive and innovative Québec in…
Read more

Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development

Aramis Biotechnologies Inc. (“Aramis”), a Canadian company pioneering and a global leader in…